Navigation Links
Insmed in Medical News

Insmed Provides Update on Supply of IPLEX(TM)

... RICHMOND, Va., July 27 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...g facility to Merck & Co., Inc. in March 2009, insmed no longer has the capability to manufacture IPLEX(...o consider its development options." About insmed ...

Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

... RICHMOND, Va., March 31 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...erck & Co., Inc. As a result of this closing, insmed has now received $130 million, the aggregate purch...d positions to employees of the Boulder facility. insmed has retained its Richmond, VA corporate office, wh...

Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND

... RICHMOND, Va., March 10 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on b...casermin_rinfabate/FDA_statement.htm . About insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants

... RICHMOND, Va., Jan. 21 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on ... target="_new"> info@premacure.com . About insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs

... RICHMOND, Va., Nov. 10 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol... today announced that Genentech, Ipsen/Tercica and insmed jointly issued the following statement: Genentech, Ipsen/Tercica, and insmed have been contacted by people living with Amyotrop...

Global Growth Factors (Blood and Tissue) Market to Reach $52.1 Billion by 2012, According to New Report by Global Industry Analysts

...imetic Therapeutics Inc, Biopharm GmbH, Bolder Biotechnology Inc, Alseres Pharmaceuticals Inc, Ceregene Inc, FibroGen Inc, FzioMed Inc, GeneMedix Plc, insmed Inc, Johnson & Johnson, Janssen-Ortho Inc, Lonza Group, Maxygen Inc, Merck Serono International SA, NsGene A/S, PeproTech Inc, Rentschler Biotechn...

Insmed to Present at Upcoming Healthcare Conferences

... RICHMOND, Va., Nov. 5 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol... and CEO of Insmed, and Steve Glover, President of insmed Therapeutic Proteins, will be presenting at the 17...archived for a period of 90 days. About Insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference

... RICHMOND, Va., Dec. 6 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceutic...ce through access to these innovative follow-on biologics. About Insmed insmed Inc. is a biopharmaceutical company with unique protein process development...
Insmed in Medical Technology

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)

... RICHMOND, Va., Oct. 14 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...t recorded 2007 sales of approximately $1 billion. insmed intends to seek approval of INS-19 and INS-20 in t... biologic version of Neulasta(R). About Insmed insmed Inc. is a biopharmaceutical company with unique pr...

Insmed CEO to Present at Congressional Briefing on Follow-On Biologics

... RICHMOND, Va., July 22 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq CM: INSM) a developer of follow-on bi...reased innovation in the field of biotechnology. insmed intends to request a meeting with the FDA to discu... combined 2007 worldwide sales of over $4 billion. insmed plans to launch its follow-on biologic versions of...

Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company

...MOND, Va., July 10, 2008 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on bi...s can be a scientific reality in the U.S. and that insmed is well positioned to be a leader in the field. De...of generic drugs today. Thus, based on these data, insmed intends to request a meeting with the FDA to discu...

Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs

...ALS Expanded Access Program Continues to Enroll - insmed Generates $2.3 million in Cost Recovery Revenue Th... RICHMOND, Va., April 29 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...velopment program. Follow-On Biologics Program insmed recently received regulatory approval from the Uni...

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)

...es Regulatory Clearance RICHMOND, Va., April 16 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceutic...trates that the products have a high degree of similarity. About Insmed insmed Inc. is a biopharmaceutical company with unique protein process development...

Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics

... RICHMOND, Va., Feb. 5 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...ry pathway currently exists for FOBs in the U.S. insmed has launched a number of public initiatives to pro...educe costs for expensive biotech drugs. Following insmed CEO Geoffrey Allan's recent testimony before the U...

Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis

...ecovery from EAP in 2007 RICHMOND, Va., Jan. 24 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceutic...ed for various other indications with unmet medical needs. About Insmed insmed Inc. is a biopharmaceutical company with unique protein process development...

Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy

... RICHMOND, Va., Dec. 18 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM), a developer of follow-on biol...he treatment of Myotonic Muscular Dystrophy (MMD). insmed is currently conducting a 24-week Phase III enabli...s Orphan Drug Designation is another milestone for insmed in our development and commercialization plan for ...

Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study

... RICHMOND, Va.--(BUSINESS WIRE)--Apr 30, 2007 - insmed Inc., (Nasdaq:INSM) today announced positive resul...re information, please visit www.ucsf.com. About insmed insmed is a biopharmaceutical company focused on the deve...

Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study

... RICHMOND, Va.--(BUSINESS WIRE)--May 3, 2007 - insmed Inc. (Nasdaq:INSM) today announced positive result...ise known as ALS or Lou Gehrig's disease). About insmed insmed is a biopharmaceutical company focused on the deve...
Insmed in Biological Technology

Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine

LOCATION: http://content.onstreammedia.com/content/multivu/18240/31602.mp3 RICHMOND, VA, January 29 /PRNewswire/ -- The American Magazine has just released a Podcast interview with Insmed Therapeutic Proteins President Steve Glover on how a generic, or follow-on biologics, industry is good fo...

Insmed to Host Second Quarter 2009 Conference Call

... RICHMOND, Va., July 31 /PRNewswire/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...ts financial results for the second quarter 2009. insmed intends to issue its quarterly financial results p...rnational), using passcode 53658791. About insmed ...

Insmed Announces Addition to the Russell 3000(R) Index

... RICHMOND, Va., June 30 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan... U.S. and global equity indexes on June 26, 2009. insmed was also added to the Russell Microcap(R) Index. ...stern Mutual Life Insurance Company. About insmed ...

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

... - insmed to Evaluate Potential Initiation of Phase II Trial...RICHMOND, Va. , June 25 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...itive function, gastrointestinal function or pain, insmed was unable to reach any conclusions regarding the ...

Insmed CEO Resigns Due to Health Concerns

... RICHMOND, Va., June 15 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...lan has played a critical role in the evolution of insmed from its inception, navigating the Company through...encountered within the biotech sector, and putting insmed in an envied position of financial strength in the...

Insmed Announces First Quarter 2009 Financial Results

... RICHMOND, Va., May 13 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...nd Net of finance and legal fees paid, insmed has received net proceeds to date of approximately... The FDA announced that it would allow insmed to provide access to IPLEX(TM) for investigational...

Insmed Regains NASDAQ Compliance

... RICHMOND, Va., May 5 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...stock price had closed above $1.00 per share. insmed will continue to trade on The NASDAQ Capital Marke... bid price compliance is now closed. About insmed ...

Insmed to Host First Quarter 2009 Conference Call

... RICHMOND, Va., April 23 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq CM: INSM ), a biopharmaceutical co...its financial results for the first quarter 2009. insmed intends to issue its quarterly financial results p...national), using passcode 62249241. About insmed ...

Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)

... insmed WILL CONTINUE TO MANAGE ALS EAP IN ITALY AND ALL I... RICHMOND, Va., March 30 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a biopharmaceutical compan...oved in their country. Under the agreement, insmed will continue to be responsible for the IPLEX(TM) ...

Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule

... RICHMOND, Va., March 25 /PRNewswire-FirstCall/ -- insmed Inc. (Nasdaq: INSM ), a developer of follow-on b... reinstated on Monday, April 20, 2009. About insmed insmed Inc. is a biopharmaceutical company with unique pr...
Other Tags
(Date:12/17/2014)... 17, 2014 Project Veritas is releasing ... videos of MIT economist and Obamacare architect Jonathan Gruber ... O’Keefe conducted the interview, which is being distributed on ... was intentional mislabeling in the Affordable Care Act in ... A two-hundred-and-fifty billion dollar per year tax grab. , ...
(Date:12/17/2014)... parents should leave prenatal picture-taking to medical professionals, the ... ultrasound imaging and heartbeat monitors to get "keepsake" images ... "Although there is a lack of evidence ... monitors, prudent use of these devices by trained health ... engineer, said in an agency news release. "Ultrasound ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... party season fast approaching, a new study reveals that states ... have fewer drunk drivers on their roads. The finding ... are better able to deter inebriated revelers from getting behind ... laws are being passed regarding drinking and driving," said study ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 A recent ... United States women as impacting skin health and beauty ... C’s of skin care.” Water and health advocate and ... a recent article describing the survey and the Four ... item in every category discussed would benefit from paying ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s ... new study providing evidence on the impact of 100% ... , Sufficient enough evidence already exists showing a negative ... drinks, with the onset of tooth decay. One question ... as 100% fruit juice, meaning it is completely natural ...
Breaking Medicine News(10 mins):Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
(Date:11/12/2014)... , Nov. 12, 2014 Crossmatch™, a ... that its U.are.U ® fingerprint readers have been ... in Central Mexico . The bakery ... to eliminate payroll issues caused by employees clocking in ... the U.are.U fingerprint readers, Montparnasse relied on paper timecards ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
Other Contents